CMC and change control
Impact assessment and implementation readiness.
Domain evidence · Biopharma and life sciences
Regulated product state, made measurable.
CMC, quality, promotional compliance, and clinical workflows with public traces and private evaluation depth.
Flagship traces · including failures
Evidence depth first. Not a leaderboard.
Includes runs that miss rubric criteria—failure is part of the product.
Workflows
Stay inside the work that brought you here.
Promotional compliance
FDA claims, fair balance, labeling consistency.
Quality and manufacturing
Cost, margin, and manufacturing decision evidence.
Category hubs
Related published task collections
Measured failure modes
What current agents miss in this domain.
- Off-label or unbalanced claims accepted
- Incomplete manufacturing margin drivers
- Document rewrites without state-transition proof